Related Experiment Videos
Atherosclerosis in transplant heart
Insights
Heart transplant atherosclerosis is a rapidly progressive condition that causes rejection and is often asymptomatic. Early diagnosis via intravascular ultrasound and angiography is crucial, with diet and diltiazem showing promise for prevention.
Area of Science:
- Cardiology
- Transplant Medicine
- Vascular Biology
Background:
- Graft atherosclerosis in heart transplants is a significant clinical challenge.
- It is characterized by rapid progression and often remains asymptomatic due to cardiac denervation.
- It is a leading cause of late transplant rejection, occurring typically after one year.
Purpose of the Study:
- To describe the unique characteristics of graft atherosclerosis compared to conventional atherosclerosis.
- To highlight diagnostic methods for early detection of graft atherosclerosis.
- To evaluate treatment and prevention strategies for heart transplant graft atherosclerosis.
Main Methods:
- Review of histopathological differences between graft and conventional atherosclerosis.
- Utilization of intravascular ultrasound and serial coronary angiography for diagnosis.
- Assessment of outcomes with dietary modifications and pharmacological interventions.
Main Results:
- Graft atherosclerosis differs histopathologically from conventional atherosclerosis.
- Intravascular ultrasound and coronary angiography enable early diagnosis.
- Dietary management of triglycerides and prophylactic diltiazem show positive outcomes.
- Surgical interventions like angioplasty and bypass graft surgery offer limited benefit.
Conclusions:
- Graft atherosclerosis is a distinct entity in heart transplant recipients, leading to rejection.
- Early diagnosis is achievable with advanced imaging techniques.
- Preventive strategies focusing on lifestyle and specific medications are effective, while retransplantation may be necessary for some patients.
Abstract:
Graft atherosclerosis in the transplant heart is essentially asymptomatic due to denervation of the transplant heart and also is rapidly progressive. After one year it is the major cause of transplant rejection. Histopathologically, graft atherosclerosis differs from the conventional atherosclerosis. Intravascular ultrasound and repeated coronary angiography help in its early diagnosis. Angioplasty and bypass graft surgery are not of much help in treatment. Preventive measures through dietary means to keep triglycerides under control and prophylactic use of calcium channel blocker diltiazem are rewarding. Many patients with graft coronary atherosclerosis end up with retransplant.